Overseas exports including Dongkuk Pharmaceutical’s intravenous anesthetic Popole injection

Popol injection in Europe and Latin America
New export of hyaluronic acid injections to China

Overseas exports such as Dongkuk Pharmaceutical, intravenous anesthetic Popole injection, etc.

Dongkuk Pharmaceutical(29,500 +0.51%)Announced on the 19th that it is actively engaged in overseas export activities.

Last year, it exported Popol injections of an intravenous anesthetic to Luxembourg, the Netherlands, Singapore and Japan as an emergency supply. This product will be exported to Colombia this month and Mexico and Bulgaria next month as an emergency supply.

Phopol injections containing propofol are known to have a calming effect on Corona 19. It is explained that it is an essential medicine that relieves pain in treating patients with dyspnea when treating severe patients. Demand continues in Central and South America and Europe, where Corona 19 is currently spreading.

In addition, details are being discussed with local companies to export long-lasting injections containing hyaluronic acid to China. Existing injections are administered with sodium hyaluronate 3 to 5 times a week to the bone joints to aid in the lack of lubrication and shock absorption of the knee joint. However, the product to be exported to China is a long-lasting injection that can monitor the patient’s progress for up to 6 months after one dose.

An official from Dongkuk Pharmaceutical said, “There are many difficulties in the export business, such as negotiations with Corona 19 are conducted online.” It is increasing,” he said.

Dongkuk Pharmaceutical recorded 56.3 billion won in exports in 2018 and 56.3 billion won in 2018. The cumulative export in the third quarter of last year was about 47.2 billion won.

Reporter Minsoo Han [email protected]

Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution

Source